Status:
UNKNOWN
Post-Chikungunya Rheumatism - Rheumatology Follow-up of Patients After 15 Years
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Chikungunya
Eligibility:
All Genders
18+ years
Brief Summary
Reunion Island was struck by a severe Chikungunya outbreak in 2005-2006. Three hundred and seven Chikungunya patients were evaluated by 4 rheumatologists 2 months after the initial infection (RHUMATOC...
Detailed Description
Reunion Island was struck in 2005-2006 by the most severe Chikungunya outbreak (seroprevalence 38% (Gérardin et al., 2013)) in a developed but previously non-immunized country, providing an unique opp...
Eligibility Criteria
Inclusion
- Patients previously included in the RHUMATOCHIK study (N=307), or diagnosed as Chikungunya-related Rheumatoid Arthritis (N=21) after telephonic screening and given their oral consent
- Chikungunya infection (positive serology and/or evocative symptoms in the epidemic context)
Exclusion
- Impossible informed consent (cognitive impairment,…).
- Lost-to-follow-up patients, refusal to participate. -Pre-existing chronic inflammatory rheumatic disease (prior to CHIKV infection)-
Key Trial Info
Start Date :
February 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT04838574
Start Date
February 20 2023
End Date
June 1 2025
Last Update
April 13 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU La Réunion (Nord)
Saint-Denis, Reunion, 97400
2
CH Ouest Réunion
Saint-Paul, Reunion
3
CHU La Réunion (Sud)
Saint-Pierre, Reunion, 97448